Blood News and Research

RSS

Regular use of fish oil supplements linked to increased heart disease risk in healthy individuals

Regular use of fish oil supplements might increase, rather than lessen, the risk of first time heart disease and stroke among those in good cardiovascular health, but may slow progression of existing poor cardiovascular health and lower the risk of death, suggest the results of a large long term study, published in the open access journal BMJ Medicine.

21 May 2024

Study links higher microplastic levels in urine to endometriosis risk

A study in Ecotoxicology and Environmental Safety finds higher levels of microplastics in urine samples from endometriosis patients compared to healthy individuals.

21 May 2024

Global study highlights major health risks: air pollution and high blood pressure top the list

A comprehensive study in The Lancet reveals the global health impacts of 88 risk factors, emphasizing the significant burden of air pollution and high blood pressure.

21 May 2024

Human body lice more efficient at transmitting Yersinia pestis than previously thought

A new laboratory study suggests that human body lice are more efficient at transmitting Yersinia pestis, the bacterium that causes plague, than previously thought, supporting the possibility that they may have contributed to past pandemics.

21 May 2024

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy and Johns Hopkins Drug Discovery.

21 May 2024

Exercise enhances efficacy of antibody therapy in leukemia patients

Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic lymphocytic leukemia, new research has shown.

21 May 2024

Generative AI enhances ER admission predictions with minimal training

Generative artificial intelligence (AI), such as GPT-4, can help predict whether an emergency room patient needs to be admitted to the hospital even with only minimal training on a limited number of records, according to investigators at the Icahn School of Medicine at Mount Sinai.

21 May 2024

Key studies on GLP-1 drugs, alpha-gal syndrome, and liver disease medications to be presented at DDW 2024

Studies examining the risks of GLP-1 weight-loss drugs, distinguishing alpha-gal syndrome from other GI disorders, and comparing medications to slow the progression of liver disease in patients with alcohol-use disorder will be presented this week at Digestive Disease Week (DDW) 2024.

21 May 2024

Transformative $8 million donation fuels pancreatic cancer research at WEHI

An exceptional $8 million, 10-year philanthropic investment will spearhead new treatments for pancreatic cancer and create a new dedicated research centre at WEHI.

21 May 2024

High price of popular diabetes drugs deprives low-income people of effective treatment

For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill their prescriptions for the medications they need to control their blood sugar.

21 May 2024

Can a coach-supported mobile health intervention reduce dementia risk?

Whether a coach-supported mHealth intervention can reduce dementia risk factors in high-risk, underserved populations.

21 May 2024

Taurine supplementation shows promise in reducing metabolic syndrome risk factors, study finds

A study in Nutrition & Diabetes meta-analyzed randomized clinical trials and found that taurine supplementation significantly reduces key risk factors for metabolic syndrome, such as high blood pressure, fasting blood glucose, and triglycerides, with no notable adverse effects.

20 May 2024

Ketogenic diets linked to cellular aging in vital organs, new study finds

Study reveals that ketogenic diets induce cellular senescence in mice, affecting organs like the kidneys and heart through AMPK and p53 pathways. These findings highlight potential long-term risks associated with ketogenic diets.

20 May 2024

Dupilumab shows promising results in Phase 3 trial for COPD with type 2 inflammation

Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug -; dupilumab -; that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers report in the New England Journal of Medicine.

20 May 2024

Early blood pressure control in ambulances shows no clear benefit for stroke patients, study finds

Study published in the New England Journal of Medicine evaluated the impact of early blood-pressure control in ambulances for acute stroke patients, finding no significant improvement in clinical outcomes compared to standard care.

20 May 2024

World's first human mini-brain with a fully functional blood-brain barrier developed

In a pioneering achievement, a research team led by experts at Cincinnati Children's have developed the world's first human mini-brain that incorporates a fully functional blood-brain barrier (BBB).

20 May 2024

Transportation of cancer nanomedicines into solid tumors

A new study conducted by the Wilhelm Lab at the University of Oklahoma examines a promising development in biomedical nanoengineering.

20 May 2024

From research to practice: Closing the divide in obesity management

As research continues to produce evidence about the underlying causes of obesity and optimal strategies to treat and manage obesity have evolved, there are disparities in application of the latest scientific advances in the clinical care that people with obesity receive.

20 May 2024

New Health Blueprint for Southwest Virginia highlights grave health challenges

A sweeping new Health Blueprint for Southwest Virginia highlights the grave health challenges that grip the rural region but also proposes solutions to help residents live longer, healthier lives.

20 May 2024

Study identifies PI3K-beta as key target in overcoming chemotherapy resistance in glioblastoma

For many patients with a deadly type of brain cancer called glioblastoma, chemotherapy resistance is a big problem.

20 May 2024

Blood News and Research

Regular use of fish oil supplements linked to increased heart disease risk in healthy individuals

Study links higher microplastic levels in urine to endometriosis risk

Global study highlights major health risks: air pollution and high blood pressure top the list

Human body lice more efficient at transmitting Yersinia pestis than previously thought

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

Exercise enhances efficacy of antibody therapy in leukemia patients

Generative AI enhances ER admission predictions with minimal training

Key studies on GLP-1 drugs, alpha-gal syndrome, and liver disease medications to be presented at DDW 2024

Transformative $8 million donation fuels pancreatic cancer research at WEHI

High price of popular diabetes drugs deprives low-income people of effective treatment

Can a coach-supported mobile health intervention reduce dementia risk?

Taurine supplementation shows promise in reducing metabolic syndrome risk factors, study finds

Ketogenic diets linked to cellular aging in vital organs, new study finds

Dupilumab shows promising results in Phase 3 trial for COPD with type 2 inflammation

Early blood pressure control in ambulances shows no clear benefit for stroke patients, study finds

World's first human mini-brain with a fully functional blood-brain barrier developed

Transportation of cancer nanomedicines into solid tumors

From research to practice: Closing the divide in obesity management

New Health Blueprint for Southwest Virginia highlights grave health challenges

Study identifies PI3K-beta as key target in overcoming chemotherapy resistance in glioblastoma

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Latest News